423 Stock Overview
Produces and sells Chinese medicine, health care products, and biological drugs in China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Dong-E-E-Jiao Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥68.69 |
52 Week High | CN¥72.91 |
52 Week Low | CN¥44.52 |
Beta | 0.67 |
1 Month Change | 1.55% |
3 Month Change | 25.00% |
1 Year Change | 43.34% |
3 Year Change | 86.91% |
5 Year Change | 68.07% |
Change since IPO | 4,192.56% |
Recent News & Updates
Are Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Investors Paying Above The Intrinsic Value?
May 21Dong-E-E-JiaoLtd's (SZSE:000423) Performance Is Even Better Than Its Earnings Suggest
Mar 31Recent updates
Are Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Investors Paying Above The Intrinsic Value?
May 21Dong-E-E-JiaoLtd's (SZSE:000423) Performance Is Even Better Than Its Earnings Suggest
Mar 31Analysts Are Updating Their Dong-E-E-Jiao Co.,Ltd. (SZSE:000423) Estimates After Its Annual Results
Mar 25Some Shareholders Feeling Restless Over Dong-E-E-Jiao Co.,Ltd.'s (SZSE:000423) P/E Ratio
Mar 21Shareholder Returns
423 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -2.4% | -2.3% | 1.3% |
1Y | 43.3% | -11.4% | -9.1% |
Return vs Industry: 000423 exceeded the CN Pharmaceuticals industry which returned -11.4% over the past year.
Return vs Market: 000423 exceeded the CN Market which returned -9.1% over the past year.
Price Volatility
423 volatility | |
---|---|
423 Average Weekly Movement | 3.4% |
Pharmaceuticals Industry Average Movement | 5.8% |
Market Average Movement | 7.2% |
10% most volatile stocks in CN Market | 10.6% |
10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 000423 has not had significant price volatility in the past 3 months.
Volatility Over Time: 000423's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1952 | 3,678 | Jie Cheng | www.dongeejiao.com |
Dong-E-E-Jiao Co.,Ltd. produces and sells Chinese medicine, health care products, and biological drugs in China. It offers compound donkey-hide gelatin paste, Enwei compound Ejiao pulp, donkey-hide gelatin jujube, Ejiao Buxue granules, and collagen powders.
Dong-E-E-Jiao Co.,Ltd. Fundamentals Summary
423 fundamental statistics | |
---|---|
Market cap | CN¥44.23b |
Earnings (TTM) | CN¥1.27b |
Revenue (TTM) | CN¥5.10b |
34.7x
P/E Ratio8.7x
P/S RatioIs 423 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
423 income statement (TTM) | |
---|---|
Revenue | CN¥5.10b |
Cost of Revenue | CN¥1.49b |
Gross Profit | CN¥3.60b |
Other Expenses | CN¥2.33b |
Earnings | CN¥1.27b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.98 |
Gross Margin | 70.69% |
Net Profit Margin | 24.98% |
Debt/Equity Ratio | 0% |
How did 423 perform over the long term?
See historical performance and comparison